Results 161 to 170 of about 2,423 (205)

Treatment of Toxic Diffuse Goiter

Postgraduate Medicine, 1969
Surgery still has a role in treatment of Graves' disease, but it is now minor. The concern about radioiodine's potential danger is unsupported by the data coming out of the large studies. The proportion of patients who become hypothyroid is substantially reduced by a modification of the standard plan of radioiodine therapy.
John B Stanbury
exaly   +3 more sources

Treatment of diffuse toxic goiter with 131I

Seminars in Nuclear Medicine, 1971
The treatment of diffuse toxic goiter with 131 I is reviewed. Consideration is given to appropriate selection of patients for radioiodine therapy, as well as to the indications and contraindications for this therapy. Methods of calculating radioiodine dose are presented.
H J Dworkin
exaly   +3 more sources

Psammoma Bodies in Diffuse Toxic Goiter

American Journal of Clinical Pathology, 1972
The frequent association of psammoma bodies and adenocarcinoma of the thyroid gland is well known. Psammoma bodies are infrequently seen in benign thyroid conditions, and many pathologists regard their presence in the thyroid gland as strongly indicative of carcinoma.
Arthur S Patchefsky
exaly   +3 more sources

TOTAL THYROIDECTOMY IN THE MANAGEMENT OF DIFFUSE TOXIC GOITER*

Journal of Clinical Endocrinology and Metabolism, 1949
IT is the purpose of this paper to present our experience with total thyroidectomy in the management of diffuse toxic goiter. This report reviews a series of 280 patients operated on by one-stage procedures during the fourteen-year period from 1935 to 1949.
A C, SCOTT, P M, RAMEY
exaly   +3 more sources

The Choice of Therapy in Toxic Diffuse Goiter

Archives of Internal Medicine, 1978
In the routine case of toxic diffuse goiter, the major consideration in the choice of initial therapy is the "cure" rate relative to the incidence of hypothyroidism and recurrence. Morbidity, patient convenience, and cost effectiveness must be balanced with relative cure rates.
Robert L Young
exaly   +4 more sources

[Diffuse toxic goiter].

Fel'dsher i akusherka, 1992
Diffuse toxic goiter is a common disease of the thyroid gland. As organospecific autoimmune condition the disease is not infrequently combined with endocrine ophthalmopathy and in this connection a more precise preparation of the patients to surgery is found to be mandatory.
I I, Dedov, G A, Mel'nichenko, G F, Aleksandrova   +2 more
openaire   +3 more sources

The choice of surgery in patients with diffuse toxic goiter

Khirurgiya. Zhurnal im. N.I. Pirogova, 2016
to define clear individual indications for different operations for diffuse toxic goiter by research of immunological markers of thyrotoxicosis recurrence probability.Long-term results of survey and treatment of 215 patients with diffuse toxic goiter are presented. Patients were divided into 2 groups.
A N, Vachev, E V, Frolova, D R, Sakhipov, N V, Morkovskikh   +3 more
openaire   +2 more sources

Carcinoma of the thyroid occurring in a diffuse toxic goiter

The American Journal of Surgery, 1961
Abstract Carcinoma of the thyroid usually is not suspected clinically with diffuse toxic goiter. When the association occurs, the cancer is usually small, often of the papillary type, especially in patients under twenty-five years of age. Often it is discovered only on microscopic examination of the surgical specimen.
E W, KONEMAN, K C, SAWYER
openaire   +2 more sources

Physiological Considerations in Treatment of Diffuse Toxic Goiter

Archives of Internal Medicine, 1961
As investigative tools become more numerous and complex, and specialized knowledge increases, there arises the hazard that the clinician may lose touch with developments in the basic sciences. Moreover, the physiologist or biochemist may fail to seek those clues to the resolution of basic problems which observation of the sick patient often provides ...
openaire   +2 more sources

[Osteocalcin in diffuse toxic goiter].

Rossiiskii meditsinskii zhurnal : organ Ministerstva zdravookhraneniia RSFSR, 1992
Bone metabolism was investigated in toxic goiter. The authors obtained evidence on high levels of osteocalcin which marks bone formation. The time of the thyroid function recovery during thyrostatic therapy and indices of phosphorus-calcium metabolism disagree indicating delayed normalization of the bone tissue metabolism.
M I, Balabolkin, T L, Khaiutina, A M, Mkrtumian   +2 more
openaire   +1 more source